Published in Obstet Gynecol on October 01, 2003
Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis (2010) 2.03
EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target. Br J Cancer (2011) 0.96
Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis. Oncol Lett (2011) 0.86
Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am (2008) 0.83
Conservatively treated glassy cell carcinoma of the cervix. World J Surg Oncol (2008) 0.81
ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma. Radiat Oncol (2012) 0.81
Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev (2010) 0.80
Fertility preservation in gynecological cancers. Clin Med Insights Reprod Health (2013) 0.78
Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003. Br J Cancer (2008) 0.78
Conservative management of adolescents with abnormal cytology and histology. J Natl Compr Canc Netw (2008) 0.77
Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer. Medicine (Baltimore) (2016) 0.75
Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Med Sci Monit (2016) 0.75
The utilization of oncology web-based resources in Spanish-speaking Internet users. Am J Clin Oncol (2012) 0.75
Factors associated with participation in cervical cancer screening among young Koreans: a nationwide cross-sectional study. BMJ Open (2017) 0.75
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86
Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81
Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med (2008) 1.70
USPSTF recommendations for STI screening. Am Fam Physician (2008) 1.68
HPV vaccination--more answers, more questions. N Engl J Med (2007) 1.64
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause (2009) 1.63
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol (2012) 1.52
Evidence-based medicine versus liquid-based cytology. Obstet Gynecol (2008) 1.43
Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev (2011) 1.33
Persistent hot flushes in older postmenopausal women. Arch Intern Med (2008) 1.28
Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause (2009) 1.23
Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol (2005) 1.18
Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med (2013) 1.17
Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2007) 1.10
Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat (2012) 1.10
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
Discontinuation of postmenopausal hormone therapy. Am J Med (2005) 1.05
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01
Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol (2009) 0.97
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns (2012) 0.87
Defining competencies for education in health care value: recommendations from the University of California, San Francisco Center for Healthcare Value Training Initiative. Acad Med (2015) 0.86
Cervical cancer screening continues to limit provision of contraception. Contraception (2005) 0.86
Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med (2012) 0.81
Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later. Ann Intern Med (2008) 0.81
Treatment patterns for cervical carcinoma in situ in Michigan, 1998-2003. J Registry Manag (2013) 0.81
Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol (2008) 0.80
New guidelines: it's complicated. Obstet Gynecol (2013) 0.80
Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol (2010) 0.79
Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol (2011) 0.78
Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? J Low Genit Tract Dis (2013) 0.78
Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages. Ann Intern Med (2007) 0.77
Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues (2013) 0.77
Cervical cancer screening among women without a cervix. JAMA (2004) 0.75
Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet Gynecol (2009) 0.75
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol (2011) 0.75
Screening pelvic examinations: right, wrong, or rite? Ann Intern Med (2014) 0.75
The new mammographic screening guidelines: what were they thinking? Obstet Gynecol (2010) 0.75
Papanicolaou testing: when does more become less? Am J Med (2005) 0.75
Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.75
Testing for human papillomavirus in women with abnormal pap smear results. JAMA (2002) 0.75
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol (2017) 0.75
Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening. Acta Cytol (2003) 0.75
Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis (2006) 0.75